相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。International patterns and trends in ovarian cancer incidence, overall and by histologic subtype
S. B. Coburn et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
MPO density in primary cancer biopsies of ovarian carcinoma enhances the indicative value of IL-17 for chemosensitivity
Raoul A. Droeser et al.
BMC CANCER (2016)
Chemotherapy Induces Programmed Cell Death-Ligand 1 Overexpression via the Nuclear Factor-κB to Foster an Immunosuppressive Tumor Microenvironment in Ovarian Cancer
Jin Peng et al.
CANCER RESEARCH (2015)
OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients
Brendan D. Curti et al.
CANCER RESEARCH (2013)
High IL-17-positive tumor immune cell infiltration is indicative for chemosensitivity of ovarian carcinoma
Raoul A. Droeser et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2013)
The immune contexture in human tumours: impact on clinical outcome
Wolf Herman Fridman et al.
NATURE REVIEWS CANCER (2012)
Localization and Density of Immune Cells in the Invasive Margin of Human Colorectal Cancer Liver Metastases Are Prognostic for Response to Chemotherapy
Niels Halama et al.
CANCER RESEARCH (2011)
Mast Cells and Neutrophils Release IL-17 through Extracellular Trap Formation in Psoriasis
Andrew M. Lin et al.
JOURNAL OF IMMUNOLOGY (2011)
Control of Immunity by the TNFR-Related Molecule OX40 (CD134)
Michael Croft
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Cancer Statistics, 2010
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2010)
Foxp3+ cell infiltration and granzyme B+/Foxp3+ cell ratio are associated with outcome in neoadjuvant chemotherapy-treated ovarian carcinoma
Martin Poelcher et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2010)
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Jacques Ferlay et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury
Li Li et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Innate IL-17-producing cells: the sentinels of the immune system
Daniel J. Cua et al.
NATURE REVIEWS IMMUNOLOGY (2010)
Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
Ninke Leffers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The significance of OX40 and OX40L to T-cell biology and immune disease
Michael Croft et al.
IMMUNOLOGICAL REVIEWS (2009)
The role of TNF superfamily members in T-cell function and diseases
Michael Croft
NATURE REVIEWS IMMUNOLOGY (2009)
The Role of OX40-Mediated Co-stimulation in T-Cell Activation and Survival
William L. Redmond et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2009)
OX40 agonist therapy enhances CD8 infiltration and decreases immune suppression in the tumor
Michael J. Gough et al.
CANCER RESEARCH (2008)
ERCC1-immunoexpression does not predict platinum-resistance in ovarian cancer
Sylvia Stadlmann et al.
GYNECOLOGIC ONCOLOGY (2008)
Differential requirements for OX40 signals on generation of effector and central memory CD4+ T cells
Pejman Soroosh et al.
JOURNAL OF IMMUNOLOGY (2007)
Selecting immunohistochemical cut-off scores for novel biomarkers of progression and survival in colorectal cancer
Inti Zlobec et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Glypican-3 expression in primary and recurrent ovarian carcinomas
Sylvia Stadlmann et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY (2007)
Expression of peroxisome proliferator activated receptor γ and cyclo-oxygenase 2 in primary and recurrent ovarian carcinoma
Sylvia Stadlmann et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
Epithelial growth factor receptor status in primary and recurrent ovarian cancer
S Stadlmann et al.
MODERN PATHOLOGY (2006)
Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers
AA Jazaeri et al.
CLINICAL CANCER RESEARCH (2005)
Ovarian cancer in Europe: Cross-sectional trends in incidence and mortality in 28 countries, 1953-2000
F Bray et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Costimulation of CD8 T cell responses by OX40
P Bansal-Pakala et al.
JOURNAL OF IMMUNOLOGY (2004)
The generation of T cell memory: a review describing the molecular and cellular events following OX40 (CD134) engagement
AD Weinberg et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2004)
Therapeutic targeting of the effector T-cell co-stimulatory molecule OX40
K Sugamura et al.
NATURE REVIEWS IMMUNOLOGY (2004)
Mutations in BRAF and KRAS characterize the development of low-grade ovarian serous carcinoma
G Singer et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer
L Zhang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Tissue microarrays in drug discovery
G Sauter et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
Diverse tumorigenic pathways in ovarian serous carcinoma
G Singer et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Ox40 costimulation enhances the development of T cell responses induced by dendritic cells in vivo
T De Smedt et al.
JOURNAL OF IMMUNOLOGY (2002)
Danger and OX40 receptor signaling synergize to enhance memory T cell survival by inhibiting peripheral deletion
JR Maxwell et al.
JOURNAL OF IMMUNOLOGY (2000)
分享论文
